Medal lecture highlights evolution in radiotherapy treatments for ocular tumours
Radiotherapy has made major advances in recent years in offering a viable treatment modality to patients with ocular tumours that were once deemed inoperable, according to Leonidas Zografos who delivered this year's EURETINA MEDAL LECTURE as part of the official Opening Ceremony at the 13th EURETINA Congress.
In a broad overview of the past, present and future of radiotherapy treatments in ocular oncology, Prof Zografos, honorary professor of ophthalmology and consultant at the Jules-Gonin Eye Hospital Lausanne ,Switzerland, told delegates that technology had come a long way since the pioneering German ophthalmologist Richard Deutschmann's first successful treatment of uveal melanoma in 1915 with seven episcleral applications of filtered mesothorium.
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.